Alprazolam

DEA Class;  Rx

Common Brand Names; Xanax, Niravam, Xanax XR

  • Antianxiety Agents; 
  • Anxiolytics, Benzodiazepine

Oral intermediate-acting benzodiazepine with minimally active metabolites
Approved for panic disorder, generalized anxiety disorder, and short-term treatment of anxiety symptoms in adults; rarely used in pediatric patients off-label
Avoid coadministration with opioids if possible due to potential for profound sedation, respiratory depression, coma, and death

Indicated for the short-term treatment of transient symptoms of anxiety.

For the treatment of generalized anxiety disorder (GAD).
For the treatment of panic disorder with or without agoraphobia.
For the treatment of anxiety and mood-symptoms associated with premenstrual dysphoric disorder (PMDD) that is unresponsive to non-pharmacologic or preferred therapy.

Documented hypersensitivity

Acute narrow angle glaucoma

Concomitant use with CYP3A4 inhibitors (itraconazole, ketoconazole)

>10% (4 mg dose)

  • Drowsiness (41%)
  • Depression (10-15%)
  • Headache (10-15%)
  • Constipation (10-15%)
  • Diarrhea (10-15%)
  • Dry mouth (10-15%)

>10% (10 mg dose)

  • Drowsiness (77%)
  • Impaired coordination (40-50%)
  • Increased appetite (30-35%)
  • Fatigue (30-35%)
  • Memory impairment (30-35%)
  • Irritability (30-35%)
  • Decreased salivation (30-35%)
  • Cognitive disorders (20-30%)
  • Insomnia (20-30%)
  • Dcreased appetite (20-30%)
  • Headache (20-30%)
  • Lightheadedness (20-30%)
  • Dysarthria (20-30%)
  • Diarrhea, constipation, and nausea/vomiting (20-30%)
  • Weight change (20-30%)
  • Nasal congestion (15-20%)
  • Decreased or increased libido (10-15%)
  • Menstrual disorder (10-15%)
  • Difficult micturition (10-15%)

1-10% (4 mg dose)

  • Tachycardia (5-10%)
  • Confusion (5-10%)
  • Insomnia (5-10%)
  • Nausea/vomiting (5-10%)
  • Blurred vision (5-10%)
  • Nasal congestion (5-10%)
  • Hypotension (1-5%)
  • Syncope (1-5%)
  • Akathisia (1-5%)
  • Dizziness (1-5%)
  • Increased salivation (1-5%)
  • Nervousness (1-5%)
  • Tremor (1-5%)
  • Weight change (1-5%)

1-10% (10 mg dose)

  • Increased salivation (5-10%)
  • Talkativeness (1-5%)
  • Incontinence (1-5%)

Anterograde amnesia reported with benzodiazepine use

Use caution in elderly patients

Use caution in debilitated patients

Use caution in severe respiratory depression; if signs and symptoms of respiratory depression, hypoventilation, or apnea occur, discontinue

Use caution in patients who recently received other respiratory depressants

Use caution in patients who are at risk of falls

May have prolonged effects in obese patients when discontinued; use caution

Not for us in acute alcohol intoxication

Use with caution in patients with hepatic or renal impairment

Myasthenia gravis (allowable in limited circumstances)

Use caution in cases of respiratory disease (COPD), sleep apnea, renal/hepatic disease, open-angle glaucoma (questionable), depression, suicide ideation, drug abuse

CNS depressant; may impair ability to perform hazardous tasks

Paradoxical reactions, including hyperactive or aggressive behavior reported

Cigarette smoking may decrease alprazolam concentration up to 50%

Mania and hypomania episodes reported in depressed patients

There is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to drug during pregnancy

Limited data from published literature reports the presence of the drug in human breast milk; there are reports of sedation and withdrawal symptoms in breastfed neonates and infants exposed to alprazolam; effects of alprazolam on lactation are unknown

Adults

10 mg/day PO.

Geriatric

10 mg/day PO.

Adolescents

Safety and efficacy have not been established.

Children

Safety and efficacy have not been established.

Infants

Not indicated.

Alprazolam

tablet: Schedule IV

  • 0.25mg

  • 0.5mg

  • 1mg

  • 2mg

tablet, extended-release: Schedule IV

  • 0.5mg

  • 1mg

  • 2mg

  • 3mg

tablet, orally disintegrating: Schedule IV

  • 0.25mg

  • 0.5mg

  • 1mg

  • 2mg

oral solution: Schedule IV

  • 1mg/mL

About the Author

You may also like these

0